Lupin Ltd. Financials

NSE BSE

15:58 Sep 12

Lupin Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2043.40

+55.40 (+2.79%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2043.40

+55.40 (+2.79%)
15:58 Sep 12

Quality

68/100
High Financial Strength

Valuation

44/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM 2025
Net Sales	16405.48	16641.66	20010.82	22707.9	23375.91
Operating Expenses +	16118.26	14843.54	16200.3	17424.59	17631.24
Raw Material	6679.56	6626.03	7100.91	7100.03	7154.31
Increase Decrease in Cost	-198.32	153.73	-457.44	-257.78	-284.69
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	2989.3	3087.15	3494.57	3964.2	4076.16
Miscellaneous Expenses	13535.42	10853.07	11979.7	11903.38	6685.46
Operating Profit	287.22	1798.12	3810.52	5283.31	5744.67
Other Income	141.69	73.36	120.17	195.82	231.99
Depreciation	1658.71	880.69	1196.81	1169.26	1220.53
Interest	142.77	274.3	311.61	294.87	318.62
Profit before tax and exceptio..	-1372.57	716.49	2422.27	4015	4437.51
Exceptional Items	0	0	0	0	0
PBT	-1372.57	716.49	2422.27	4015	4437.51
Provision for Taxation	137.15	268.8	486.7	708.74	715.33
Net Profit	-1509.72	447.69	1935.57	3306.26	3722.18
NET Profit after MI	-1528.04	430.08	1914.48	3281.62	3699.34
EPS	-33.65	9.41	41.87	71.95	81.08
Operating Profit Margin (%)	1.75	10.8	19.04	23.27	24.58
Net Profit Margin (%)	-9.31	2.58	9.57	14.45	15.83

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	46.90	46.90	47.00	47.00	47.00
FII	21.20	21.50	22.00	21.50	19.30
MF	19.40	17.60	16.90	16.90	16.20
Others	6.20	7.80	7.80	8.20	10.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: